Skip to main content

PLx Pharma Winddown Corp.

PLXPDelisted May 2, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001497504

PLx Pharma Winddown Corp. was delisted on May 2, 2023; its insiders filed their last Form 4 on Mar 16, 2022; 35 institutions reported holding it in 13F filings for Q1 2023, worth $477.6K in total; no superinvestor held it.

Holders of 5% or more of PLXP

Holders whose latest Schedule 13D or 13G filing reports 5% or more of PLx Pharma Winddown Corp., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of PLx Pharma Winddown Corp. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

8 Schedule 13D and 13G filings on PLx Pharma Winddown Corp., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on PLXP
Filed (ET)FilerFormStakeChangeEvent dateFiling
Apr 6, 2023Park West Asset Management LLC13GOld format–––SEC
Feb 14, 2023MSD Partners, L.P.13G/AOld format–––SEC
Feb 16, 2022White Rock Capital Management LP13G/AOld format–––SEC
Feb 14, 2022Rosalind Advisors, Inc.13G/AOld format–––SEC
Feb 11, 2022Level One Partners, LLC13G/AOld format–––SEC
Jun 11, 2021Park West Asset Management LLC13D/AOld format–––SEC
Mar 16, 2021Level One Partners, LLC13GOld format–New–SEC
Jan 22, 2021Rosalind Advisors, Inc.13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell PLx Pharma Winddown Corp. shares.

No Form 144 notices for PLx Pharma Winddown Corp. are on file.